CDG Therapeutics’ intellectual property includes four issued patents on the founders’ core technology and improvements:
patent #7,084,105 issued August 1, 2006
patent # 7,301,010 issued November 27, 2007
patent # 7,338,766 issued March 4, 2008
patent # 7,381,701 issued June 3, 2008Additionally, CDG Therapeutics patent portfolio includes numerous international patent applications on the founders’ core technology and improvements. CDG Therapeutics continues to file new utility and provisional patent applications as our research advances.
The company possesses an exclusive worldwide license to commercialize the founders’ discoveries. These exclusive rights were granted to CDG by the University of Illinois in exchange for royalties on any commercial products to emerge from the company’s efforts, as well as an equity stake held by the University. The royalty rates and equity stake granted to the University by CDG are consistent with those between other development stage companies and their respective university partners.
